News & AnalysisAnodyne Nanotech takes in $4.2m seedBoston-based Anodyne Nanotech, a biotech company, has secured $4.2 million in seed funding.ByIris Dorbian3 May 2021•1 min readJavaScript is required to read this article. Please enable it in your browser and reload the page.DealsHealthcareBriefs